Tomohiro Morio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Step in the compact CPC (Cell Processing Center) and discover its processes and the technology it uses to achieve advanced cell therapy and regenerative therapy.

Two men in their 30s with no underlying health issues or allergies died within days of receiving their second jab of Moderna Inc.'s COVID-19 vaccine this month, the health ministry announced Aug. 28.

The arrival of COVID-19 in Japan in early 2020 prompted a concerted research effort at RIKEN. A strong research capacity in immunology, molecular biology...

news COVID-19 vaccine anaphylaxis rate not serious concern: Japan gov't experts The Mainichi © The Mainichi Tomohiro Morio, left, head of the Ministry of Health, Labor and Welfare's expert panel for investigating adverse reactions to vaccinations, is seen in conversation ahead of a meeting of the panel at the ministry in Tokyo, on March 12, 2021. (Mainichi/Kentaro Ikushima) TOKYO -- Only seven of the 17 instances of anaphylaxis following coronavirus vaccinations reported by Japanese medical institutions qualify as true cases under international standards, the health ministr...

With the new cases, the number of confirmed instances of anaphylaxis following coronavirus inoculation across the country rose to eight.